Ariel Investments’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $249M | Buy |
1,444,183
+16,412
| +1% | +$3.04M | 2.79% | 10 |
|
|
2025
Q4 | $285M | Sell |
1,427,771
-62,327
| -4% | -$11.3M | 3.08% | 7 |
|
|
2025
Q3 | $233M | Buy |
1,490,098
+74,750
| +5% | +$11.9M | 2.49% | 13 |
|
|
2025
Q2 | $215M | Buy |
1,415,348
+314,572
| +29% | +$41.9M | 2.43% | 14 |
|
|
2025
Q1 | $166M | Buy |
1,100,776
+33,449
| +3% | +$5.61M | 1.95% | 24 |
|
|
2024
Q4 | $197M | Buy |
1,067,327
+169,640
| +19% | +$32.7M | 2.1% | 20 |
|
|
2024
Q3 | $177M | Sell |
897,687
-8,450
| -0.9% | -$1.76M | 1.81% | 26 |
|
|
2024
Q2 | $187M | Sell |
906,137
-26,670
| -3% | -$6.04M | 2.03% | 21 |
|
|
2024
Q1 | $253M | Sell |
932,807
-117,891
| -11% | -$28.2M | 2.49% | 7 |
|
|
2023
Q4 | $248M | Sell |
1,050,698
-15,902
| -1% | -$3.13M | 2.47% | 5 |
|
|
2023
Q3 | $209M | Buy |
1,066,600
+18,760
| +2% | +$3.85M | 2.21% | 12 |
|
|
2023
Q2 | $220M | Buy |
1,047,840
+364,786
| +53% | +$72.6M | 2.09% | 13 |
|
|
2023
Q1 | $138M | Buy |
683,054
+45,292
| +7% | +$10.3M | 1.32% | 35 |
|
|
2022
Q4 | $139M | Sell |
637,762
-12,736
| -2% | -$2.78M | 1.41% | 31 |
|
|
2022
Q3 | $128M | Buy |
650,498
+60,859
| +10% | +$13.1M | 1.41% | 34 |
|
|
2022
Q2 | $126M | Buy |
589,639
+379,844
| +181% | +$92.8M | 1.26% | 35 |
|
|
2022
Q1 | $59.6M | Buy |
209,795
+30,148
| +17% | +$9.3M | 0.53% | 57 |
|
|
2021
Q4 | $67.7M | Sell |
179,647
-3,558
| -2% | -$1.38M | 0.57% | 52 |
|
|
2021
Q3 | $75.6M | Sell |
183,205
-37,894
| -17% | -$15.7M | 0.69% | 50 |
|
|
2021
Q2 | $81.8M | Sell |
221,099
-189,974
| -46% | -$63.4M | 0.77% | 47 |
|
|
2021
Q1 | $119M | Sell |
411,073
-1,793
| -0.4% | -$498K | 1.17% | 32 |
|
|
2020
Q4 | $103M | Sell |
412,866
-77,476
| -16% | -$18.5M | 1.16% | 30 |
|
|
2020
Q3 | $111M | Sell |
490,342
-134,264
| -21% | -$27.9M | 1.61% | 21 |
|
|
2020
Q2 | $109M | Sell |
624,606
-60,977
| -9% | -$9.73M | 1.66% | 21 |
|
|
2020
Q1 | $86.5M | Sell |
685,583
-164,511
| -19% | -$24.7M | 1.52% | 23 |
|
|
2019
Q4 | $130M | Buy |
850,094
+8,497
| +1% | +$1.18M | 1.63% | 22 |
|
|
2019
Q3 | $111M | Buy |
841,597
+26,090
| +3% | +$3.5M | 1.48% | 23 |
|
|
2019
Q2 | $116M | Sell |
815,507
-30,935
| -4% | -$4.2M | 1.45% | 23 |
|
|
2019
Q1 | $123M | Sell |
846,442
-141,729
| -14% | -$18.6M | 1.53% | 23 |
|
|
2018
Q4 | $112M | Sell |
988,171
-265,795
| -21% | -$33.3M | 1.56% | 22 |
|
|
2018
Q3 | $169M | Sell |
1,253,966
-63,620
| -5% | -$7.85M | 1.87% | 17 |
|
|
2018
Q2 | $148M | Sell |
1,317,586
-43,691
| -3% | -$4.72M | 1.66% | 20 |
|
|
2018
Q1 | $145M | Buy |
1,361,277
+8,082
| +0.6% | +$871K | 1.66% | 17 |
|
|
2017
Q4 | $148M | Sell |
1,353,195
-326,871
| -19% | -$35.6M | 1.67% | 17 |
|
|
2017
Q3 | $181M | Sell |
1,680,066
-270,301
| -14% | -$27.8M | 2.11% | 9 |
|
|
2017
Q2 | $197M | Sell |
1,950,367
-110,053
| -5% | -$10.1M | 2.33% | 7 |
|
|
2017
Q1 | $185M | Buy |
2,060,420
+483,564
| +31% | +$41.1M | 2.18% | 6 |
|
|
2016
Q4 | $120M | Buy |
1,576,856
+150,014
| +11% | +$11.4M | 1.42% | 25 |
|
|
2016
Q3 | $119M | Sell |
1,426,842
-37,288
| -3% | -$3.13M | 1.44% | 26 |
|
|
2016
Q2 | $121M | Sell |
1,464,130
-202,825
| -12% | -$16.7M | 1.52% | 22 |
|
|
2016
Q1 | $127M | Sell |
1,666,955
-75,935
| -4% | -$5.62M | 1.53% | 21 |
|
|
2015
Q4 | $140M | Buy |
1,742,890
+68,560
| +4% | +$4.94M | 1.68% | 16 |
|
|
2015
Q3 | $106M | Sell |
1,674,330
-5,320
| -0.3% | -$382K | 1.32% | 26 |
|
|
2015
Q2 | $118M | Sell |
1,679,650
-78,795
| -4% | -$5.83M | 1.33% | 25 |
|
|
2015
Q1 | $139M | Sell |
1,758,445
-245,610
| -12% | -$18.1M | 1.56% | 18 |
|
|
2014
Q4 | $128M | Buy |
2,004,055
+7,785
| +0.4% | +$488K | 1.47% | 21 |
|
|
2014
Q3 | $119M | Buy |
1,996,270
+45,613
| +2% | +$2.61M | 1.54% | 22 |
|
|
2014
Q2 | $104M | Sell |
1,950,657
-58,605
| -3% | -$3.22M | 1.28% | 25 |
|
|
2014
Q1 | $121M | Sell |
2,009,262
-619,955
| -24% | -$36.1M | 1.48% | 19 |
|
|
2013
Q4 | $139M | Sell |
2,629,217
-120,688
| -4% | -$6.06M | 1.71% | 16 |
|
|
2013
Q3 | $127M | Buy |
2,749,905
+15,455
| +0.6% | +$709K | 1.85% | 16 |
|
|
2013
Q2 | $112M | Buy |
+2,734,450
| New | +$117M | 1.83% | 17 |
|
Other funds holding CRL
VCM
VPM
Ariel Investments's CRL Position: Q1 2026 in Review
Ariel Investments increased its Charles River Laboratories (CRL) stake by 1.1% in Q1 2026, buying an estimated $3.04M and bringing the position to 1,444,183 shares worth $249M. The position accounts for 2.79% of the portfolio, ranked #10.
Ariel Investments first reported a position in CRL in Q2 2013 and has held it in 52 quarters since. The position peaked at $285M in Q4 2025. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.
- Ariel Investments held 1,444,183 shares of Charles River Laboratories worth $249M as of Q1 2026.
- Ariel Investments bought 16,412 Charles River Laboratories shares in Q1 2026, an estimated $3.04M.
- Charles River Laboratories made up 2.79% of Ariel Investments's portfolio in Q1 2026, its #10 holding.
- Ariel Investments first reported a position in Charles River Laboratories in Q2 2013 and has held it in 52 quarters since.
- Ariel Investments's Charles River Laboratories position peaked at $285M in Q4 2025.
- 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.
Based on Ariel Investments's 13F filing for Q1 2026, filed 14 May 2026.